François Simard, MD: No financial relationships to disclose
Learning Objectives / Objectifs d'apprentissage:
At the end of this session participants will be able to / Au terme de cette conférence, vous serez:
describe common indications for antiplatelets/anticoagulation therapies in athletes;
explain challenges in evaluating the bleeding and thrombotic risks in the high-performance athletic population; and
discuss the potential of a personalised approach in anti-thrombotic prescription in high-performance athletes.
Youth and fitness are not enough to prevent thrombosis in high performance athletes. Do you know the indications and common risk factors for thrombosis in this population? Dr Simard will address these aspects and more.
